Devices Addressed In US FDA's New Regenerative Medicine Framework

The framework includes two draft guidance documents and two final guidances. One of the drafts, which focuses on the regulation of devices used with regenerative medicine, implements a provision of the 21st Century Cures Act and strongly suggests that most of these products will be regulated via class II.

Scientist

More from Regulation

More from Policy & Regulation